If you have a compelling family history of ovarian cancer that is not explained by a mutation in the BRCA1 or BRCA2 gene, it is possible that a mutation in the RAD51D gene could be the explanation.
RAD51D – A New Hereditary Ovarian Cancer Gene With Important Implications
Posted on August 7, 2011 Written by Leave a Comment
Family History of Cancer Changes Over Time: Why You Need to Keep Your Primary Care Doctor Updated
Posted on July 15, 2011 Written by Leave a Comment
If you are interested in cancer prevention, you may know that for common cancers family history is one of the most important and useful tools that we have to identify people at elevated risk (who are likely to benefit most from more intensive screening and/or preventative measures). Despite this fact, discussion of family history often [...]
New Financial Assistance Program for Young Women with BRCA1 and BRCA2 Mutations Needing Help Paying for Screening Breast MRI
Posted on July 6, 2011 Written by Leave a Comment
In a previous post we mentioned a Christina Applegate appearance on Oprah to discuss both learning that she (Ms. Applegate) had Hereditary Breast and Ovarian Cancer risk due to a BRCA1 mutation and the aftermath. Since then, The Christina Applegate Foundation has worked to promote awareness of the importance of breast MRI screening for high-risk women. However, one key impediment for some women is the cost of MRI. Now, Right Action for Women is doing something to address this problem.
Tony Snow, Former Bush Press Secretary, Dies at 53: A Reminder About Familial Colon Cancer and Opportunities for Prevention
Posted on July 20, 2008 Written by 2 Comments
Tony Snow, the conservative writer, commentator, and former Bush administration Press Secretary, died on the morning of July 12 at the age of 53 of colorectal cancer.
It’s worth mentioning that Mr. Snow had a family history of colon cancer, as his mother died of the disease when he was 17 years old.
Where You Get Your Mammogram Matters!
Posted on June 25, 2008 Written by Leave a Comment
A research group led by Dr. Stephen Taplin of the National Cancer Institute has published a paper in the June 18th issue of the Journal of the National Cancer Institute that assesses whether certain factors differing between mammography facilities are associated with better interpretive accuracy on screening mammograms.